AngioDynamics News
News
0
Ticker
ANGO
ISIN
US03475V1017
AngioDynamics Eulerpool News
AngioDynamics Stock News
AngioDynamics is being monitored by journalists and investors worldwide. We gather the latest AngioDynamics news here.
- February 19 ·Benzinga
- February 13 ·Yahoo
- February 6 ·Yahoo
- February 5 ·Yahoo
- February 5 ·Yahoo
- February 4 ·Yahoo
- February 3 ·Yahoo
- January 30 ·Yahoo
- January 14 ·SeekingAlpha
- January 14 ·Yahoo
AngioDynamics Stock Press Releases
AngioDynamics regularly publishes news on the company's website that are relevant for investors.
AngioDynamics News 2026
This page contains all current news, analysis and press releases for AngioDynamics stock (ANGO, ISIN: US03475V1017). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at AngioDynamics.
AngioDynamics Stock
AngioDynamics AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products.